The Microdose Psychedelics Capital Conference virtual event will commence on Thursday, March 24, 2022, 1:30 EST, and investors, family officers, budding entrepreneurs, psychedelic researchers, medical & science specialists and health professionals are invited to attend. The agenda of the conference will include discussions, keynotes, and insights from world-class speakers, top companies, as well as the latest IPOs, all addressing the potential and scope of investments in the psychedelic sector.
The conference will explore specific opportunities in the psychedelic investment sector, along with discussions on the latest innovations in drug development, pertinent laws and regulations, and…
To learn more, please visit https://ibn.fm/t47sm.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.